Related Experiment Video
Updated: Jan 8, 2026

04:04
Asthma Detection Research Based on Voice Signal Processing and Machine Learning
Published on: July 22, 2025
883
Natural Language Processing for Enhanced Clinical Decision Support in Allergy Verification for Medication
Juan Pablo Botero-Aguirre1, Michael Andrés García-Rivera2
1Department of Artificial Intelligence, Hospital Pablo Tobón Uribe, Colombia.
Mayo Clinic Proceedings. Digital Health
|December 15, 2025
Summary
A new BERT-based named entity recognition (NER) model effectively extracts allergy information from Spanish electronic health records, aiding in medication safety by detecting prescription errors.
Area of Science:
- Natural Language Processing
- Clinical Informatics
- Pharmacovigilance
Background:
- Electronic health records (EHRs) contain valuable patient data but are often unstructured.
- Extracting specific information like allergy details from Spanish EHRs is challenging.
- Automated methods are needed to improve data extraction and patient safety.
Purpose of the Study:
- To develop and validate a BERT-based named entity recognition (NER) model for extracting allergy information from Spanish EHRs.
- To assess the model's performance in identifying medication names, adverse reactions, and prescription errors.
- To evaluate the model's utility in clinical decision support for enhancing medication safety.
Main Methods:
- A BERT-based NER model was fine-tuned on 16,176 manually annotated allergy-related entities from Spanish EHRs.
- The dataset was split into training (80%) and testing (20%) subsets.
- Model performance was evaluated using accuracy, recall, F1 score, sensitivity, specificity, and Cohen κ, with expert review as the gold standard.
Main Results:
- The model achieved an overall F1 score of 0.80, with high performance for medication names (F1=0.91) and adverse reactions (F1=0.85).
- It demonstrated high specificity (99.98%) in identifying non-allergic cases and detected prescription errors in 0.96% of cases.
- The model showed substantial agreement with expert annotations (weighted κ=0.7797).
Conclusions:
- The Spanish-language BERT-based NER model shows strong performance in extracting allergy-related information and identifying non-allergic cases.
- The model holds promise for clinical decision support, particularly in enhancing medication safety despite moderate sensitivity.
- This study demonstrates the feasibility of using NER models for improving medication safety in Spanish-speaking healthcare settings.
Related Concept Videos
Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Allergic Reactions
31.9K
Overview
31.9K
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K

